2024年4月22日发(作者:怎么联系上门安装宽带)
ialendotoxins
Maizestarch
Sodiumchloride
Agar,accordingtogellingpower
Purifiedwater
1.0g
5.0g
10.0gto15.0g
1000ml
Sterilisebyheatinginanautoclaveat121°Cfor15min.
Ifthesolutionhasinsufficientneutralisingcapacitythe
concentrationofpolysorbate80orlecithinmaybeincreased.
Alternatively,theneutralisersmentionedinTable2.6.13.-3
maybeadded.
Hydratetheagar,dissolvebyheatingtoboilingwith
ssary,adjustthepHsothat
Table2.6.13.-3.–Inactivatorsforantimicrobialagentstobe
aftersterilisationitis7.3±isebyheatinginan
addedtobufferedsodiumchloride-peptonesolutionpH7.0
autoclaveat121°ocoolto45-50°C;
Inactivator
Typeofan-ConcentrationComment
add,wherenecessary,gentamicinsulphatecorrespondingto
timicrobial
20mgofgentamicinbaseandpourintoPetridishes.
agent
SodiumAddafter
Phenolics4g/l
MediumR(Lactosemonohydratesulphitemedium)
Pancreaticdigestofcasein
Yeastextract
Sodiumchloride
Lactosemonohydrate
Cysteinehydrochloride
Purifiedwater
5.0g
2.5g
2.5g
10.0g
0.3g
1000ml
Organo-
mercurals
Halogens
Quaternary
laurilsulfate
Polysorbate80
andlecithin
Eggyolk
Sodium
thioglycolate
Sodium
thiosulphate
Eggyolk
30g/land3g/l
5ml/l-50ml/l
0.5g/l-5g/l
5g/l
5ml/l-50ml/l
Addafter
sterilisationof
bufferedsodium
chloride-peptone
solutionpH7.0
ammonium
sterilisationof
Dissolve,adjusttopH7.1±0.1andfillto8mlin
compounds
bufferedsodium
16mm×160mmtubescontainingasmallDurhamtube.
chloride-peptone
Sterilisebyheatinginanautoclaveat121°Cfor15minand
solutionpH7.0
storeat4°C.
Beforeuse,heatthemediumfor5mininawater-bathand
achtube0.5mlofa12g/lsolutionofsodium
01/2005:20614
metabisulphiteRand0.5mlofa10g/lsolutionofferric
ammoniumcitrate,bothsolutionsbeingfreshlyprepared
IALENDOTOXINS
andfilteredthroughmembranes(poresize:0.45µm).
AgarmediumS(R2A)
Thetestforbacterialendotoxinsisusedtodetector
Yeastextract
0.5g
quantifyendotoxinsofgram-negativebacterialorigin
usingamoebocytelysatefromhorseshoecrab(Limulus
Proteosepeptone
0.5g
polyphemusorTachypleustridentatus).Thereare
0.5g
3techniquesforthistest:thegel-clottechnique,which
Caseinhydrolysate
isbasedongelformation;theturbidimetrictechnique,
0.5g
Glucose
basedonthedevelopmentofturbidityaftercleavageofan
0.5g
endogenoussubstrate;andthechromogenictechnique,
Starch
0.3g
basedonthedevelopmentofcolouraftercleavageofa
Dipotassiumhydrogenphosphate
syntheticpeptide-chromogencomplex.
0.024g
Magnesiumsulphate,anhydrous
Thefollowing6methodsaredescribedinthepresent
0.3g
chapter:
Sodiumpyruvate
Agar
Purifiedwater
15.0g
1000ml
MethodA.
Gel-clotmethod:limittest
MethodB.
Gel-clotmethod:semi-quantitativetest
MethodC.
Turbidimetrickineticmethod
genickineticmethod
genicend-pointmethod
MethodF.
Turbidimetricend-pointmethod
vent
ofdoubtordispute,thefinaldecisionismadebasedupon
methodAunlessotherwiseindicatedinthemonograph.
Thetestiscarriedoutinamannerthatavoidsendotoxin
contamination.
Apparatus
Depyrogenateallglasswareandotherheat-stableapparatus
nlyused
minimumtimeandtemperatureis30minutesat250°
employingplasticapparatus,suchasmicrotitreplatesand
pipettetipsforautomaticpipetters,useapparatusshown
tobefreeofdetectableendotoxinandofinterferingeffects
forthetest.
NOTE:Inthischapter,theterm‘tube’includesalltypesof
receptacles,forexamplemicrotitreplatewells.
161
AdjustthepHsothataftersterilisationitis7.2±0.2.
Sterilisebyheatinginanautoclaveat121°Cfor15min.
NEUTRALISINGAGENTS
Neutralisingagentsmaybeusedtoneutralisetheactivity
ybeaddedtobuffered
sodiumchloride-peptonesolutionpH7.0,preferablybefore
isedtheirefficacyandnon-toxicitytowards
micro-organismsaredemonstrated.
Atypicalneutralisingfluidhasthefollowingcomposition:
Polysorbate80
Lecithin(egg)
Histidinehydrochloride
Peptone(meatorcasein)
Sodiumchloride
Potassiumdihydrogenphosphate
Disodiumhydrogenphosphatedihydrate
Purifiedwater
30g
3g
1g
1g
4.3g
3.6g
7.2g
1000ml
GeneralNotices(1)applytoallmonographsandothertexts
ialendotoxinsEUROPEANPHARMACOPOEIA5.0
Preparationofthestandardendotoxinstocksolution
Thestandardendotoxinstocksolutionispreparedfrom
anendotoxinreferencestandardthathasbeencalibrated
againsttheInternationalStandard,forexampleendotoxin
standardBRP.
EndotoxinisexpressedinInternationalUnits(IU).The
equivalenceinIUoftheInternationalStandardisstatedby
theWorldHealthOrganisation.
NOTE:OneInternationalUnit(IU)ofendotoxinisequalto
oneEndotoxinUnit(E.U.).
Followthespecificationsinthepackageleafletandonthe
labelforpreparationandstorageofthestandardendotoxin
stocksolution.
Preparationofthestandardendotoxinsolutions
Aftervigorouslymixingthestandardendotoxinstock
solution,prepareappropriateserialdilutionsofthissolution
usingwaterforbacterialendotoxinstest(waterforBET).
Usethesolutionsassoonaspossibletoavoidlossofactivity
byadsorption.
Preparationofthetestsolutions
Preparethetestsolutionsbydissolvingordilutingactive
substancesormedicinalproductsusingwaterforBET.
Somesubstancesorpreparationsmaybemoreappropriately
ssary,
adjustthepHofthetestsolution(ordilutionthereof)sothat
thepHofthemixtureofthelysateandtestsolutionfalls
withinthepHrangespecifiedbythelysatemanufacturer.
ThisusuallyappliestoaproductwithapHintherangeof6.0
aybeadjustedbytheuseofacid,baseora
suitablebuffer,asrecommendedbythelysatemanufacturer.
Acidsandbasesmaybepreparedfromconcentratesor
solidswithwaterforBETincontainersfreeofdetectable
smustbevalidatedtobefreeofdetectable
endotoxinandinterferingfactors.
DeterminationoftheMaximumValidDilution
TheMaximumValidDilution(MVD)isthemaximum
allowabledilutionofasampleatwhichtheendotoxinlimit
inetheMVDusingthefollowing
formulae:
—inml/mliftheendotoxinlimitisspecifiedbyvolume
(IU/ml).
λ
=
thelabelledlysatesensitivityinthegel-clot
technique(IU/ml)orthelowestpointused
inthestandardcurveoftheturbidimetricor
chromogenictechniques.
Endotoxinlimit:theendotoxinlimitforactivesubstances
administeredparenterally,definedonthebasisofdose,is
equalto:
GEL-CLOTTECHNIQUE(METHODSAANDB)
Thegel-clottechniqueallowsdetectionorquantification
ofendotoxinsandisbasedonclottingofthelysateinthe
centrationofendotoxins
requiredtocausethelysatetoclotunderstandardconditions
reboththeprecision
andvalidityofthetest,confirmthelabelledlysatesensitivity
andperformthetestforinterferingfactorsasdescribed
atorytesting.
ATORYTESTING
(i)Confirmationofthelabelledlysatesensitivity
Confirmin4replicatesthelabelledsensitivityλ,expressed
inIU/ml,ofthelysatesolutionpriortouseinthetest.
Confirmationofthelysatesensitivityiscarriedoutwhena
newbatchoflysateisusedorwhenthereisanychangein
theexperimentalconditionswhichmayaffecttheoutcome
ofthetest.
Preparestandardsolutionsofatleast4concentrations
equivalentto2λ,λ,0.5λand0.25λbydilutingthestandard
endotoxinstocksolutionwithwaterforBET.
Mixavolumeofthelysatesolutionwithanequalvolume
of1ofthestandardsolutions(suchas0.1mlaliquots)in
ngletestvialsorampoulescontaining
lyophilisedlysateareemployed,addsolutionsdirectlyto
tethereactionmixturefora
constantperiodaccordingtotherecommendationsofthe
lysatemanufacturer(usuallyat37±1°Cfor60±2min),
eintegrityofthegel:fortubes,
takeeachtubeinturndirectlyfromtheincubatorandinvert
itthroughapproximately180°
firmgelhasformedthatremainsinplaceuponinversion,
tisnegativeifanintact
gelisnotformed.
Thetestisnotvalidunlessthelowestconcentrationofthe
standardsolutionsshowsanegativeresultinallreplicate
tests.
Theend-pointisthelastpositiveresultintheseriesof
atethemean
valueofthelogarithmsoftheend-pointconcentrationsand
thentheantilogarithmofthemeanvalueusingthefollowing
expression:
Geometricmeanend-pointconcentration=
K
M
=
=
thresholdpyrogenicdoseofendotoxinper
kilogramofbodymassinasinglehourperiod,
maximumrecommendeddoseofproductper
kilogramofbodymassinasinglehourperiod.
f
=
=
sumofthelogend-pointconcentrationsofthe
dilutionseriesused,
numberofreplicates.
Theendotoxinlimitforactivesubstances
administeredparenterallyisspecifiedinunitssuch
asIU/ml,IU/mg,IU/Unitofbiologicalactivity,etc.,in
monographs.
Concentrationoftestsolution:
—inmg/mliftheendotoxinlimitisspecifiedbymass
(IU/mg),
—inUnits/mliftheendotoxinlimitisspecifiedbyunitof
biologicalactivity(IU/Unit),
162
Thegeometricmeanend-pointconcentrationisthemeasured
sensitivityofthelysatesolution(IU/ml).Ifthisisnotless
than0.5λandnotmorethan2λ,thelabelledsensitivityis
confirmedandisusedinthetestsperformedwiththislysate.
(ii)Testforinterferingfactors
PreparesolutionsA,B,CandDasshowninTable2.6.14.-1,
andusethetestsolutionsatadilutionlessthantheMVD,
notcontaininganydetectableendotoxins,operatingas
atorytesting,(i)Confirmationof
thelabelledlysatesensitivity.
Seetheinformationsectionongeneralmonographs(coverpages)
发布者:admin,转转请注明出处:http://www.yc00.com/xitong/1713754850a2311990.html
评论列表(0条)